Inactivation of protein synthesis stimulating activity in serum by cellsEdvardas Kaminskas · 1973

Deficient repair of DNA lesions in Alzheimer's disease fibroblastsJames C. Li; Edvardas Kaminskas · 1985

[Part 1: Biological Sciences] || Accumulation of DNA Strand Breaks and Methotrexate CytotoxicityJames C. Li and Edvardas Kaminskas · Proceedings of the National Academy of Sciences of the United States of America · 1984

Repair of DNA damage induced by oxygen radicals in human non-proliferating and proliferating lymphocytesKaminskas, Edvardas; Li, James C. · Mutation Research/DNA Repair · 1992

Novel oral anticoagulants and reversal agents: Considerations for clinical developmentSarich, Troy C.; Seltzer, Jonathan H.; Berkowitz, Scott D.; Costin', James; Curnutte, John T.; Gibson, C. Michael; Hoffman, Maureane; Kaminskas, Edvardas; Krucoff, Mitchell W.; Levy, Jerrold H.; Mintz, Paul D.; Reilly, Paul A.; Sager, Philip T.; Singer, Daniel E.; Stockbridge, Norman; Weitz, Jeffrey I.; Kowey, Peter R. · American Heart Journal · 2015

FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the <i>BRAF</i> V600 MutationOneal, Patricia A.; Kwitkowski, Virginia; Luo, Lola; Shen, Yuan Li; Subramaniam, Sriram; Shord, Stacy; Goldberg, Kirsten B.; McKee, Amy E.; Kaminskas, Edvardas; Farrell, Ann; Pazdur, Richard · The Oncologist · 2018

FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaGormley, Nicole J.; Ko, Chia-Wen; Deisseroth, Albert; Nie, Lei; Kaminskas, Edvardas; Kormanik, Natasha; Goldberg, Kirsten B.; Farrell, Ann T.; Pazdur, Richard · Clinical Cancer Research · 2017